Royalty Pharma PLC header image

Royalty Pharma PLC

RPRX

Equity

ISIN GB00BMVP7Y09 / Valor 55041695

NASDAQ (2026-11-02)
USD 66.52-0.98%

Royalty Pharma PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Royalty Pharma PLC is a publicly traded investment company that buys and manages royalty and revenue interests in prescription drugs and biologics, providing upfront capital to drug developers, investors and, occasionally, larger pharmaceutical companies in exchange for a portion of future product sales and milestone payments. It does not conduct drug discovery or commercialization; instead, it builds a diversified portfolio of royalty streams across therapeutic areas and product life cycles and seeks to generate returns from the sales performance of those underlying medicines. The firm funds acquisitions through capital markets and debt, structures bespoke transactions to transfer commercial and development risk, and its revenue profile is directly tied to the commercial success and lifecycle timing of the drugs that underpin its royalty assets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

77.2%1Y
142%3Y
74.5%5Y

Performance

23.1%1Y
23.5%3Y
23.8%5Y

Volatility

Market cap

29620 M

Market cap (USD)

Daily traded volume (Shares)

2,873,392

Daily traded volume (Shares)

1 day high/low

25.455 / 25.18

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Cardinal Health Inc
Cardinal Health Inc Cardinal Health Inc Valor: 196652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.54%USD 254.33
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%USD 407.88
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%USD 208.45
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.88%USD 9.90
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%USD 29.62
PFIZER LIMITED
PFIZER LIMITED PFIZER LIMITED Valor: 912046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.33%INR 3,637.90
Camurus AB
Camurus AB Camurus AB Valor: 30510553
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%SEK 674.00
CVS Group PLC
CVS Group PLC CVS Group PLC Valor: 3457960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.49%GBP 13.60
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%USD 14.13
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.24%USD 41.24